Miss Shari Pepplinkhuizen
Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial
Event: ESC Congress 2024
Topic: Device Treatment
Session: Subcutaneous and extravascular defibrillators: already mainstream?
Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation
Event: ESC Congress 2024
Topic: Device Treatment
Session: Subcutaneous and extravascular defibrillators: already mainstream?
Clinical relevance of the single-lead ECG of the Apple Watch
Event: ESC Congress 2022
Topic: Remote Patient Monitoring and Telehealth
Session: e-Cardiology/Digital health - Remote monitoring 1
Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence
Event: EHRA 2022
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: ePosters Day 2
Exercise-optimised programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation of S-ICDs
Event: EHRA 2021
Topic: Genetic Aspects of Arrhythmias
Session: Scientific reports
Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs
Event: EHRA 2021
Topic: Implantable Cardioverter-Defibrillator (ICD)
Session: Oral abstract session - Devices
